Biocure Technology Inc. (CSE:CURE.X)
Canada flag Canada · Delayed Price · Currency is CAD
0.0550
0.00 (0.00%)
At close: Aug 13, 2026

Biocure Technology Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1201114
Market Cap Growth
10.00%867.35%-88.89%29.45%-92.14%-49.55%
Enterprise Value
1201317
Last Close Price
0.060.070.010.140.091.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-1.720.960.120.88-0.47-16.26
P/TBV Ratio
-0.960.120.88--
P/FCF Ratio
--11.42---
P/OCF Ratio
--11.42---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/FCF Ratio
--12.94---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.100.040.040.03-0.04-4.45
Debt / FCF Ratio
--3.62---
Net Debt / Equity Ratio
-0.090.010.020.02-0.02-4.26
Net Debt / EBITDA Ratio
-----0.06-2.17
Net Debt / FCF Ratio
-1.21-0.232.31-0.17-0.05-3.35
Quick Ratio
0.050.100.040.030.010.05
Current Ratio
0.050.110.040.030.030.57
Return on Equity (ROE)
-599.29%-7.05%-17.83%---
Return on Assets (ROA)
-18.27%-1.97%-10.03%-32.40%-13.50%-24.91%
Return on Capital Employed (ROCE)
46.60%-4.00%-22.90%-64.00%28.90%-432.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-206.71%-6.79%-167.53%-128.63%-133.13%-8.14%
FCF Yield
-4.49%-5.05%8.75%-15.40%-75.83%-7.82%
Buyback Yield / Dilution
-85.83%-50.69%-1.23%13.15%-3.76%-4.98%